- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Tarrytown Today
By the People, for the People
Regeneron Pharmaceuticals Announces Quarterly Dividend Increase
The biopharmaceutical company will pay a $0.94 dividend per share on March 5th.
Published on Feb. 21, 2026
Got story updates? Submit your updates here. ›
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced it will issue a quarterly dividend of $0.94 per share on March 5th to shareholders of record as of February 20th. This represents a 6.8% increase from the company's previous quarterly dividend of $0.88 per share.
Why it matters
Regeneron's dividend increase signals the company's strong financial performance and confidence in its future growth prospects. As a leading biopharmaceutical firm, Regeneron's dividend payouts are closely watched by investors as an indicator of the company's stability and commitment to shareholder returns.
The details
The ex-dividend date is set for February 20th. Regeneron's dividend payout ratio is currently 9.6%, meaning its dividend is well covered by earnings. Analysts expect the company to earn $38.02 per share next year, suggesting the $3.76 annual dividend will have a future payout ratio of 9.9%.
- Regeneron announced the quarterly dividend on January 30th, 2026.
- The dividend of $0.94 per share will be paid on March 5th, 2026.
- The ex-dividend date is set for February 20th, 2026.
The players
Regeneron Pharmaceuticals, Inc.
A U.S.-based biotechnology company founded in 1988 and headquartered in Tarrytown, New York. Regeneron focuses on discovering, developing, manufacturing and commercializing medicines for serious medical conditions.
What’s next
Regeneron's next quarterly dividend payment is scheduled for June 2026, with the ex-dividend date and record date to be announced at a later time.
The takeaway
Regeneron's dividend increase demonstrates the company's financial strength and commitment to returning value to shareholders. As a leading biopharmaceutical firm, Regeneron's dividend payouts are closely watched by investors as a sign of the company's stability and growth potential.
